Brief: Surface Oncology Inc - QTRLY Total Revenue $1.6 Million Versus $38.6 Million
05/05/2021 11:43
May 5 (Reuters) - Surface Oncology Inc SURF.O :
* QTRLY TOTAL REVENUE $1.6 MILLION VERSUS $38.6 MILLION
* Q1 LOSS PER SHARE $0.37
* AS OF MARCH 31, 2021, CASH, CASH EQUIVALENTS WERE $171.0
MILLION, COMPARED TO $175.1 MILLION ON DECEMBER 31, 2020
* SURFACE ONCOLOGY - CONTINUES TO PROJECT CURRENT CASH,
EQUIVALENTS AND ANTICIPATED NEAR-TERM MILESTONE FROM GSK ARE
SUFFICIENT TO FUND CO THROUGH 2023
* Q1 EARNINGS PER SHARE VIEW $-0.41, REVENUE VIEW $1.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: [https://bit.ly/3ei4M9l]
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing